Showing results (111-120 of 142) with videos related to
Sort By:
Pageof 15
British Journal of Haematology|February 8, 2020
Composite and sequential lymphoma between classical Hodgkin lymphoma and primary mediastinal lymphoma/diffuse large B-cell lymphoma, a clinico-pathological series of 25 casesGuillaume Aussedat, Alexandra Traverse-Glehen, Aspasia Stamatoullas, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 22, 2022
Brentuximab Vedotin Plus AVD for First-Line Treatment of Early-Stage Unfavorable Hodgkin Lymphoma (BREACH): A Multicenter, Open-Label, Randomized, Phase II TrialLuc-Matthieu Fornecker, Julien Lazarovici, Igor Aurer, et al.American Journal of Hematology|June 10, 2018
Efficacy of chemotherapy or chemo-anti-PD-1 combination after failed anti-PD-1 therapy for relapsed and refractory Hodgkin lymphoma: A series from Lysa centersCédric Rossi, Julia Gilhodes, Marie Maerevoet, et al.Journal of Neurology|August 29, 2024
Anti-RGS8 paraneoplastic cerebellar ataxia is preferentially associated with a particular subtype of Hodgkin's lymphomaElise Peter, Nicolas Lundahl Ciano-Petersen, Le-Duy Do, et al.Haematologica|May 28, 2026
Nivolumab with or without vinblastine for first-line treatment of elderly patients with Hodgkin lymphoma and coexisting medical conditions: the Niviniho phase II Lysa studyJulien Lazarovici, Sandy Amorim, Krimo Bouabdallah, et al.Blood Advances|February 26, 2025
Characterization and treatment outcomes of malignant histiocytoses in a retrospective series of 141 cases in FranceCamille Bigenwald, Damien Roos-Weil, Arnaud Pagès, et al.Blood|September 22, 2020
Mutational landscape of gray zone lymphomaClémentine Sarkozy, Stacy S Hung, Elizabeth A Chavez, et al.Blood|May 19, 2010
Cytogenetic aberrations and their prognostic value in a series of 330 splenic marginal zone B-cell lymphomas: a multicenter study of the Splenic B-Cell Lymphoma GroupMarta Salido, Cristina Baró, David Oscier, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 10, 2015
An Immunogenetic Signature of Ongoing Antigen Interactions in Splenic Marginal Zone Lymphoma Expressing IGHV1-2*04 ReceptorsVasilis Bikos, Maria Karypidou, Evangelia Stalika, et al.Blood Advances|October 20, 2023
High PDL1/PDL2 gene expression correlates with worse outcome in primary mediastinal large B-cell lymphomaVincent Camus, Pierre-Julien Viailly, Fanny Drieux, et al.Pageof 15